Gonzalez F, Valjalo R
World J Transplant. 2016; 5(4):338-47.
PMID: 26722662
PMC: 4689945.
DOI: 10.5500/wjt.v5.i4.338.
Venkatakrishnan K, von Moltke L, Greenblatt D
Clin Pharmacokinet. 2000; 38(2):111-80.
PMID: 10709776
DOI: 10.2165/00003088-200038020-00002.
Martin J, Daoud A, Schroeder T, First M
Pharmacoeconomics. 1999; 15(4):317-37.
PMID: 10537952
DOI: 10.2165/00019053-199915040-00001.
Jones T
Clin Pharmacokinet. 1997; 32(5):357-67.
PMID: 9160170
DOI: 10.2165/00003088-199732050-00002.
Campana C, Regazzi M, Buggia I, Molinaro M
Clin Pharmacokinet. 1996; 30(2):141-79.
PMID: 8906896
DOI: 10.2165/00003088-199630020-00004.
Primary care of the renal transplant patient.
Pirsch J, Friedman R
J Gen Intern Med. 1994; 9(1):29-37.
PMID: 8133348
DOI: 10.1007/BF02599140.
Pharmacokinetic drug interactions with antimicrobial agents.
Gillum J, Israel D, Polk R
Clin Pharmacokinet. 1993; 25(6):450-82.
PMID: 8119047
DOI: 10.2165/00003088-199325060-00005.
Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.
Scholz J, Schulz M, Steinfath M, Hover S, Bause H
J Mol Med (Berl). 1995; 73(3):145-7.
PMID: 7633952
DOI: 10.1007/BF00198243.
Cyclosporine: immunology, toxicity and pharmacology in experimental animals.
Thomson A, Whiting P, Simpson J
Agents Actions. 1984; 15(3-4):306-27.
PMID: 6395677
DOI: 10.1007/BF01972366.
Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.
BLOCK L, Sutter P, Mihatsch M
Klin Wochenschr. 1983; 61(21):1053-62.
PMID: 6358655
DOI: 10.1007/BF01496465.
Immunosuppressive activity and toxicity of cyclosporin A in rats pretreated with high dose cyclophosphamide.
Brown P, Thomson A, Whiting P, Davidson R, Simpson J
Agents Actions. 1985; 17(1):67-72.
PMID: 4083181
DOI: 10.1007/BF01966684.
Extraction ratio of cyclosporine in a liver transplant patient with organ rejection.
Venkataramanan R, Ptachcinski R, Burckart G, Yang S, Starzl T
J Pharm Sci. 1985; 74(8):901-2.
PMID: 3897511
PMC: 3022509.
DOI: 10.1002/jps.2600740824.
Cyclosporine trough concentration monitoring in liver transplant patients.
Burckart G, Ptachcinski R, Venkataramanan R, Iwatsuki S, Esquivel C, Van Thiel D
Transplant Proc. 1986; 18(6 Suppl 5):188-93.
PMID: 3538569
PMC: 2999908.
Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.
Burckart G, Venkataramanan R, Ptachcinski R, Starzl T, Griffith B, Hakala T
Transplant Proc. 1986; 18(6 Suppl 5):129-36.
PMID: 3538565
PMC: 2846538.
Interaction between cyclosporin A and phenobarbitone.
Carstensen H, Jacobsen N, Dieperink H
Br J Clin Pharmacol. 1986; 21(5):550-1.
PMID: 3521692
PMC: 1401037.
DOI: 10.1111/j.1365-2125.1986.tb02843.x.
Clinical pharmacokinetics of cyclosporin.
Ptachcinski R, Venkataramanan R, Burckart G
Clin Pharmacokinet. 1986; 11(2):107-32.
PMID: 3514043
DOI: 10.2165/00003088-198611020-00002.
Clinical pharmacokinetics of ketoconazole.
Daneshmend T, Warnock D
Clin Pharmacokinet. 1988; 14(1):13-34.
PMID: 3280211
DOI: 10.2165/00003088-198814010-00002.
Drug interactions that matter. A critical reappraisal.
McInnes G, Brodie M
Drugs. 1988; 36(1):83-110.
PMID: 3063497
DOI: 10.2165/00003495-198836010-00006.
Treatment of systemic fungal infections: recent progress and current problems.
Walsh T, Pizzo A
Eur J Clin Microbiol Infect Dis. 1988; 7(4):460-75.
PMID: 2846299
DOI: 10.1007/BF01962595.
Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.
DMello A, Venkataramanan R, Satake M, Todo S, Takaya S, Ptachcinski R
Res Commun Chem Pathol Pharmacol. 1989; 64(3):441-54.
PMID: 2781141
PMC: 2974324.
